Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Colonic Neoplasms

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Colonic Neoplasms in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacKenzie, WM1
Hoskin, DW1
Blay, J1
Eidelman, O1
Guay-Broder, C1
van Galen, PJ1
Jacobson, KA1
Fox, C1
Turner, RJ1
Cabantchik, ZI1
Pollard, HB1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Colonic Neoplasms

ArticleYear
Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.
    Cancer research, 1994, Jul-01, Volume: 54, Issue:13

    Topics: Adenocarcinoma; Adenosine; Animals; Antibodies; CD3 Complex; Cell Adhesion; Colonic Neoplasms; Kille

1994
A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Jun-15, Volume: 89, Issue:12

    Topics: 2-Chloroadenosine; Adenocarcinoma; Adenosine; Cell Line; Chlorides; Chromosome Deletion; Colonic Neo

1992